Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study of drug interactions between enzalutamide, morphine and edoxaban in patients with prostate cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    The Netherlands
  • Study of Pembrolizumab, Vibostolimab, and Belzutifan for Patients with Metastatic Castration-Resistant Prostate Cancer

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    Austria Denmark Finland France Germany Ireland +5
  • Study of Stereotactic Body Radiotherapy with or without Darolutamide for Patients with Oligorecurrent Prostate Cancer

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium
  • Study on Prostate Cancer Treatment: Comparing Goserelin Acetate, Leuprorelin Acetate, Degarelix, and Apalutamide in Patients with Biochemical Progression After Surgery

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Belgium
  • Study on Aspirin’s Effect on Recurrence and Survival in Patients with Non-Metastatic Breast, Colon, Rectal, Stomach, Esophageal, and Prostate Cancer

    Not recruiting

    3 1 1
    Investigated Drugs:
    Ireland
  • Study on Stereotactic Body Radiation Therapy with or without Durvalumab for Patients with Oligometastatic Hormone-Sensitive Prostate Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study on Apalutamide and Drug Combination for Patients with Metastatic Castration-Sensitive Prostate Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    France Germany Poland
  • Study of Lorigerlimab and Docetaxel for Patients with Metastatic Castration-Resistant Prostate Cancer

    Not recruiting

    2 1 1 1
    Belgium Bulgaria France Poland Spain
  • Study of Apalutamide and Androgen Deprivation Therapy for Patients with High-Risk Prostate Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    Czechia France Germany Italy The Netherlands Poland +1
  • Study on the Effectiveness and Safety of Apalutamide and GnRH Agonist in Patients with High-Risk Prostate Cancer Undergoing Radiation Therapy

    Not recruiting

    3 1 1
    Investigated Diseases:
    Belgium Czechia France Germany Italy Poland +3